Rankings
▼
Calendar
CRIS
Curis, Inc.
$14M
Q4 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$3M
-15.5% YoY
Gross Profit
$3M
94.7% margin
Operating Income
-$5M
-186.9% margin
Net Income
-$6M
-215.6% margin
EPS (Diluted)
$-3.59
QoQ Revenue Growth
-3.2%
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$5M
Stock-Based Comp.
$631,000
Balance Sheet
Total Assets
$37M
Total Liabilities
$42M
Stockholders' Equity
-$4M
Cash & Equivalents
$24M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$3M
$3M
-15.5%
Gross Profit
$3M
$3M
-15.8%
Operating Income
-$5M
-$7M
+27.8%
Net Income
-$6M
-$8M
+26.0%
Revenue Segments
Gross Royalty Revenue
$3M
100%
← FY 2018
All Quarters
Q1 2019 →
CRIS Q4 2018 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena